Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by BigShoes13on Sep 22, 2014 5:30pm

135 Views

Post# 22959937

RE:RE:Early Morning Email

$285 Billion... well surely SBM can get 2% of this action. That means we are worth $5.7 billion... lets round up to $6.0 billion to include our skin lightener... That puts SBM at a fair market value of $48 per share.... what is the market thinking.... I sure hope Valeant doesn't try to low ball you shareholders and offer something ridiculous like $10 per share... I assume you would all rightly turn that down....

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity